Click below to explore OSSIO press releases and recent news articles written about OSSIOfiber® Intelligent Bone Regeneration Technology.
New biointegrative system offers screw-like stability with the utility of a trimmable nail, leaving no permanent implant behind.
OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment of Gary J. Pruden to its Board of Directors. Pruden.
Complete Offering of Implant Sizes and Shapes Provides Surgeons and their Patients an Intelligent Bone Regeneration Alternative to Metal Fixation
Award recognizes company’s dedication to transforming the orthopedic market through its first-of-kind bio-integrative bone fixation solution
The first commercial cases were hammertoe repairs successfully performed at Polaris Surgery Center in Westerville, Ohio.
OSSIO, an orthopedic fixation company, today announced the closing of $22 million in equity financings led by OCV Partners, a Los Angeles based venture capital firm, with continued participation from existing investors Ortho Vision LLC and Secocha Ventures.
OSSIO, an orthopedic fixation company, today announced that its OSSIOfiberTM Bone Pin Family has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA).
In the News
A new class of bio-integrative implants’: Dr. Stuart Miller on orthobiologics and implant selection.
FDA clears Ossio’s Bio-Integrative Bone Fixation Implant
Ortho dev Ossio wins FDA nod for bio-integrative bone pins
FDA clears absorbable foot and ankle implant
Biointegrative orthopedic fixation material receives FDA clearance: 5 things to know
FDA clears Ossio’s integrative mineral bone pins for orthopedic surgeries
Whether it’s a new advance for treating the Charcot foot, a promising wound care dressing, a cartilage allograft to address osteochondral defects or a medication for psoriasis, the latest roundup of innovations may offer treatment options for potentially improved outcomes.